Co-crystals or salts of psilocybin and methods of treatment therewith
US12060328B2 · kind B2 · utility
0Cited by
33References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 3, 2023 |
| Grant date | Aug 13, 2024 |
| Priority date | — |
| Expiry date | Mar 3, 2043 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07B2200/13
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The invention relates to a co-crystal or salt comprising psilocybin and a co-former. The co-crystal or salt is useful in methods of treating or preventing a disease or condition selected from depression, anxiety, death anxiety, demoralization, adjustment disorders, hopelessness, suicidal ideation, desire for hastened death, cocaine-related disorders, opioid-related disorders and stimulant-related disorders in a patient. A kit comprising the co-crystal or salt is also described.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.